Researchers present sensor prototype that can rapidly, precisely, and cost-effectively measure molecular signals for cancer
The CRISPR/Cas technology can do more than alter genes. A research team at the University of Freiburg is using what are known as gene scissors – which scientists can use to edit genetic material – in order to better diagnose diseases such as cancer. In a study, the researchers introduce a microfluidic chip which recognizes small fragments of RNA, indicating a specific type of cancer more rapidly and precisely than the techniques available up to now. The results are recently published in the scientific journal “Advanced Materials.” They also tested the CRISPR biosensor on blood samples taken from four children who had been diagnosed with brain tumors. “Our electrochemical biosensor is five to ten times more sensitive than other applications which use CRISPR/Cas for RNA analysis,” explains Freiburg microsystems engineer Dr. Can Dincer. He is leading the research team together with biologist Prof. Dr. Wilfried Weber, of the University of Freiburg. “We’re doing pioneering work in Germany and Europe for this new application of gene scissors,” Dincer emphasizes.
Short molecules known as microRNA (miRNA) are coded in the genome, but unlike other RNA sequences, they are not translated into proteins. In some diseases, such as cancer or the neurodegenerative disease, Alzheimer’s, increased levels of miRNA can be detected in the blood. Doctors are already using miRNAs as a biomarker for certain types of cancer. Only the detection of a multitude of such signaling molecules allows an appropriate diagnosis. The researchers are now working on a version of the biosensor that recognizes up to eight different RNA markers simultaneously.
The CRISPR biosensor works as follows: A drop of serum is mixed with reaction solution and dropped onto the sensor. If it contains the target RNA, this molecule binds with a protein complex in the solution and activates the gene scissors – in a way similar to a key opening a door lock. Thus activated, the CRISPR protein cuts off, or cleaves, the reporter RNAs that are attached to signaling molecules, generating an electrical current. The cleavage results in a reduction of the current signals which can be measured electrochemically and indicates if the miRNA that is being sought is present in the sample. “What’s special about our system is that it works without the replication of miRNA, because in that case, specialized devices and chemicals would be required. That makes our system low-cost and considerably faster than other techniques or methods,” explains Dincer. He is working on new sensor technologies at the Freiburg Center for Interactive Materials and Bioinspired Technologies (FIT) and together with Prof. Dr. Gerald Urban at the Department of Microsystems Engineering (IMTEK).
Weber, a professor of synthetic biology at the cluster of excellence CIBSS – the Centre for Integrative Biological Signalling Studies of the University of Freiburg – emphasizes how important the interdisciplinary environment at CIBSS is for such a development: “The biologists at Freiburg work together on these technologies with their colleagues from the engineering and materials sciences. That opens new, exciting routes to solutions.” The researchers are aiming to further develop the system in about five to ten years to become the first rapid test for diseases with established microRNA markers that can be used right at the doctor’s office. “The laboratory equipment must nevertheless become easier to handle,” says Weber.
Learn more: Using Gene Scissors to Detect Diseases
The Latest Google Headlines on:
The Latest Bing News on:
- Chronic wasting disease found for first time in a wild deer in Green Lake Countyon June 19, 2021 at 3:57 pm
Chronic wasting disease, a fatal deer disease, has been found for the first time in Green Lake County. With the finding, 58 of Wisconsin's 72 counties are now considered CWD-affected, according to the ...
- World Sickle Cell Day 2021: SCD is Preventable if Carrier Detection, Genetic Testing is done early in Pregnancy, Says ICMR-NIIH Directoron June 19, 2021 at 4:59 am
Sickle Cell Disease (SCD) is a lifelong disease and currently bone marrow transplantation is the only curative option. However, the symptoms can be effectively managed with adequate counselling and sp ...
- Scientists develop low-cost lab-on-paper device for rapid and accurate detection of SARS-CoV-2on June 18, 2021 at 8:45 am
A team of scientists from the University of Connecticut, USA, has developed a low-cost lab-on-paper technology to rapidly and easily detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...
- AnPac Bio's First Disease Treatment Patent Granted, and Its Cancer Treatment Project Secured Multi-Million Dollar Fundson June 18, 2021 at 3:36 am
AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and ...
- Foresight Diagnostics to Present a Vision of the New Standard of Lymphoma MRD Detection at the 16th International Conference on Malignant Lymphomaon June 17, 2021 at 3:07 am
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse ...
- Foresight diagnostics to show vision of the new standard of lymphoma MRD detection at ICMLon June 16, 2021 at 9:00 pm
Forsight to present clinical data of their blood-based MRD detection platform for DLBCL that detects relapse 200 days earlier than other methods.
- Touchless technology could enable early detection and treatment of eye diseases that cause blindnesson June 14, 2021 at 11:25 am
A new non-contact laser imaging system developed by engineering researchers, is designed to detect telltale signs of major blinding diseases in retinal blood and tissue that typically go unseen until ...
- A touchless technology for early detection of eye diseaseson June 14, 2021 at 9:12 am
A non-contact laser imaging system could help doctors diagnose and treat eye diseases that cause blindness much earlier than is now possible.
- New York Turns to Smart Thermometers for Disease Detection in Schoolson June 6, 2021 at 8:56 am
The technology company Kinsa will distribute as many as 100,000 internet-connected thermometers through the city’s elementary schools.
The Latest Google Headlines on:
The Latest Bing News on:
- Engineer Develops Lab-on-Paper SARS-CoV-2 Diagnostic by CRISPRon June 16, 2021 at 3:16 am
Changchun Liu's low-cost, easy-to-use device provides accurate results within an hour (Pixabay) Changchun Liu, ...
- Manifold roles of β-arrestins in GPCR signaling elucidated with siRNA and CRISPR/Cas9on June 10, 2021 at 5:00 pm
Studies based on CRISPR/Cas9-generated cell lines suggested that β-arrestins are dispensable for ERK1/2 activation. Luttrell et al. compared the effects of siRNA-mediated and CRISPR/Cas9-mediated ...
- Could Gold Leaf Be The Midas Touch For Affordable Virus Testing?on June 6, 2021 at 5:00 pm
By doing this they formed a biosensor which detects a current when ... Tests based on LAMP and CRISPR have already been used to identify viral infections like Zika or COVID-19 in areas where ...
- 7 Best Biotech Stocks To Buy in 2021 as Innovation Takes Center Stageon May 19, 2021 at 4:21 am
Some of the exciting areas of innovation development in biotech include biosensors ... making it worth a serious look. Crispr has been on many biotech investors’ radars for a few years now.
- The 221b Foundation and LogicInk Announce License Agreement to Utilize Sherlock Biosciences’ CRISPR Technology to Develop Instrument-free Diagnostic for COVID-19on May 3, 2021 at 5:51 am
today announced the organizations have entered into a license agreement to enable LogicInk to utilize Sherlock Biosciences’ CRISPR technology to develop an instrument-free diagnostic biosensor ...
- $13.86 Billion Synthetic Biology Market, 2026 - Market to Grow at a CAGR of Approx 36% - ResearchAndMarkets.comon April 29, 2021 at 9:03 am
Advancement in genome engineering such as CRISPR and DNA synthesis technologies ... Highly specific, tiny biosensors can be engineered to spot an enormous range of molecules such as hydrocarbon ...
- EAGER SENTINELS: The PCR-free Biosensor for a Fast, Simple, and Sensitive Detection of RNA.on February 16, 2021 at 2:09 pm
Specifically, the proposed biosensor will be based on the newly discovered CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeat – CRISPR associated) nuclease that shows high ...
- Life Sciences A - Zon August 13, 2020 at 12:25 pm
In recognition of the International Day of Action for Women's Health, we spoke to Dame Claire Bertschinger about what changes need to made to achieve gender equality.
- Scientists Are Using CRISPR To “Program” Living Cellson May 25, 2017 at 2:13 am
An artist’s impression of connected CRISPR-dCas9 NOR gates ... engineer immune cells to respond to cancer markers or cellular biosensors to diagnose infectious diseases. Essentially, we ...
- The Age of Gene Editing: Everything You Need To Know About CRISPR/Cas9on June 22, 2016 at 11:01 am
CRISPR/Cas9 is a revolutionary gene editing ... such as oral drug delivery and the production of biosensors. Drug Development: Engineering cells to optimize a high yield generation of drug ...